Trial Profile
A Phase III Open-label, Multi-centre Study to Assess the Pharmacokinetics, Efficacy, and Safety of Biostate in Paediatric Subjects with von Willebrand Disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemorrhage; Von Willebrand disease
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- Sponsors CSL Behring
- 03 Feb 2014 New trial record